This study tests two different chemotherapy plus immunotherapy combinations in people with advanced lung cancer that has a specific marker (TTF-1 negative). About 136 participants will be randomly assigned to one of two treatment groups. The goal is to see which combination helps…
Phase: PHASE4 • Sponsor: Nikolaj Frost MD • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC